2019
DOI: 10.1124/mol.119.115824
|View full text |Cite
|
Sign up to set email alerts
|

Generation and Characterization of an Abcc1 Humanized Mouse Model (hABCC1) with Knockout Capability

Abstract: ATP-binding cassette (ABC) transporters such as ABCB1 (Pglycoprotein), ABCC1 (MRP1), and ABCG2 (BCRP) are well known for their role in rendering cancer cells resistant to chemotherapy. Additionally, recent research provided evidence that, along with other ABC transporters (ABCA1 and ABCA7), they might be cornerstones to tackle neurodegenerative diseases. Overcoming chemoresistance in cancer, understanding drug-drug interactions, and developing efficient and specific drugs that alter ABC transporter function ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 59 publications
2
12
0
Order By: Relevance
“…Our group has previously established a humanized ABCC1 mouse model, 543 and an ABCA7 model is under characterization. Here, we generated knock-in mouse models producing a chimeric protein that is completely human except for one amino acid.…”
Section: Part Ii: Pipeline Development To Gain Novel Diagnostics and Therapeuticsmentioning
confidence: 99%
See 2 more Smart Citations
“…Our group has previously established a humanized ABCC1 mouse model, 543 and an ABCA7 model is under characterization. Here, we generated knock-in mouse models producing a chimeric protein that is completely human except for one amino acid.…”
Section: Part Ii: Pipeline Development To Gain Novel Diagnostics and Therapeuticsmentioning
confidence: 99%
“…Here, we generated knock-in mouse models producing a chimeric protein that is completely human except for one amino acid. 543 In addition, as this gene was flanked by loxP sites, this humanized model can be knocked out in specific cell populations and at a specific age. 543 Models such as these represent the future of pre-clinical drug candidate evaluation.…”
Section: Part Ii: Pipeline Development To Gain Novel Diagnostics and Therapeuticsmentioning
confidence: 99%
See 1 more Smart Citation
“…It is important to remember that there can be molecular and physiological differences between species, such as expression levels, substrate specificity, and transport efficiency in the case of ABC transporters (see Section 3.6). Therefore, models with humanized ABC transporters, as P-gp and BCRP, have been developed to better represent drug transport in humans [236][237][238][239]. Diverse techniques are used to evaluate the permeability of molecules into the brain and their clearance and obtain important ADME, toxicity, and PK-PD parameters (reviewed in [5,6,8,133,240].…”
Section: In Vivo Models and Assaysmentioning
confidence: 99%
“…Positron emission tomography (PET) imaging with 6-bromo-7-[ 11 C]methylpurine ([ 11 C]BMP) has been used to measure the activity of MRP1 in the brain and lungs of mice and rats [ 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. [ 11 C]BMP itself is not transported by MRP1 but is in vivo rapidly and quantitatively converted by cytosolic glutathione- S -transferases into the corresponding glutathione conjugate S-(6-(7-[ 11 C]methylpurinyl)) glutathione ([ 11 C]MPG), which is a substrate of MRP1 [ 9 ].…”
Section: Introductionmentioning
confidence: 99%